This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly




Verve Therapeutics’ stock rallies by a record 80% on Eli Lilly’s premium purchase price for the drug-development company.



Source link

  • Related Posts

    Trump threatens Iran’s leader, demands ‘unconditional surrender’

    U.S. President Donald Trump speaks to reporters aboard Air Force One after departing early from the the G7 summit in Canada to return to Washington, June 17, 2025. Kevin Lamarque…

    Solar stocks plunge on Senate bill’s tax-credit phaseout, but analysts say investors should be happy

    S&P components Enphase Energy and First Solar move lower by double-digit percentages. Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *